HR | 95% CI | p Value | |
Multivariate analysis | |||
Model A (Clinical characteristics, treatments and LV parameters) AIC=453.006 | |||
Age | 1.020 | 0.990 to 1.052 | 0.187 |
PCI | 0.386 | 0.193 to 0.772 | 0.007 |
Nicorandil | 0.243 | 0.098 to 0.597 | 0.002 |
LVEF* | 0.609 | 0.451 to 0.824 | 0.001 |
Model B (Clinical characteristics, treatments and MIBG parameters) AIC=426.402 | |||
Age | 1.004 | 0.973 to 1.037 | 0.298 |
PCI | 0.430 | 0.229 to 0.807 | 0.009 |
Nicorandil | 0.325 | 0.129 to 0.816 | 0.017 |
WR* | 4.091 | 2.756 to 6.074 | <0.001 |
Model C (Clinical characteristics, treatments, LV and MIBG parameters) AIC=455.004 | |||
Age | 1.005 | 0.972 to 1.037 | 0.315 |
PCI | 0.428 | 0.228 to 0.806 | 0.010 |
Nicorandil | 0.319 | 0.125 to 0.814 | 0.016 |
LVEF* | 0.961 | 0.707 to 1.535 | 0.337 |
WR* | 5.339 | 3.152 to 9.041 | <0.001 |
↵* Per 1 SD increase.
AIC, Akaike information criterion; LVEF, left ventricular ejection fraction; MIBG, m-iodobenzylguanidine; PCI, percutaneous coronary intervention; WR, washout rate.